Literature DB >> 11694524

Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets.

Libby A Blair1, Leonard B Maggi, Anna L Scarim, John A Corbett.   

Abstract

Environmental factors, such as viral infection, have been implicated as potential triggering events leading to the initial destruction of pancreatic beta cells during the development of autoimmune diabetes. Double-stranded RNA (dsRNA), the active component of a viral infection that stimulates antiviral responses in infected cells, has been shown in combination with interferon-gamma (IFN-gamma) to stimulate inducible nitric oxide synthase (iNOS) expression and nitric oxide production and to inhibit beta cell function. Interferon regulatory factor-1 (IRF-1), the activation of which is induced by dsRNA, viral infection, and IFN-gamma, regulates the expression of many antiviral proteins, including PKR, type I IFN, and iNOS. In this study, we show that IRF-1 is not required for dsRNA + IFN-gamma-stimulated iNOS expression and nitric oxide production by mouse islets. In contrast to islets, dsRNA + IFN-gamma fails to induce iNOS expression or nitric oxide production by macrophages isolated from IRF-1(-/-) mice; however, dsRNA + IFN-gamma induces similar levels of IL-1 release by macrophages isolated from both IRF-1(-/-) and IRF-1(+/+) mice. Importantly, we show that dsRNA- or dsRNA + IFN-gamma-stimulated IRF-1 expression by mouse islets and peritoneal macrophages is independent of PKR. These results indicate that IRF-1 is required for dsRNA + IFN-gamma-induced iNOS expression and nitric oxide production by mouse peritoneal macrophages but not by mouse islets. These findings suggest that dsRNA + IFN-gamma stimulates iNOS expression by two distinct PKR-independent mechanisms; one that is IRF-1-dependent in macrophages and another that is IRF-1-independent in islets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694524     DOI: 10.1074/jbc.M109819200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists.

Authors:  Dirk Werling; Jayne C Hope; Chris J Howard; Thomas W Jungi
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack.

Authors:  C Gysemans; H Callewaert; F Moore; M Nelson-Holte; L Overbergh; D L Eizirik; C Mathieu
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

3.  CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.

Authors:  Zachary R Shaheen; Aaron Naatz; John A Corbett
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422

4.  Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses.

Authors:  Rujuan Dai; Rebecca A Phillips; Ebru Karpuzoglu; Deena Khan; S Ansar Ahmed
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

5.  The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts.

Authors:  Devangi R Mehta; Ali A Ashkar; Karen L Mossman
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 6.  Macrophage Expression of Inflammatory Genes in Response to EMCV Infection.

Authors:  Zachary R Shaheen; John A Corbett
Journal:  Biomolecules       Date:  2015-08-18

7.  Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid.

Authors:  Ji Young Lee; Wansu Park
Journal:  Molecules       Date:  2011       Impact factor: 4.411

8.  Down-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1.

Authors:  Tiina Leppänen; Riku Korhonen; Mirka Laavola; Riina Nieminen; Raimo K Tuominen; Eeva Moilanen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.